Search research articles
Contact Us
Filters
Showing results (61-70 of 68) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 68 results.
Cancers
|
March 28, 2024
Natural Killer Cell Dysfunction in Premenopausal <i>BRCA1</i> Mutation Carriers: A Potential Mechanism for Ovarian Carcinogenesis
Shaun Haran, Kantaraja Chindera, May Sabry, et al.
Plos One
|
December 14, 2011
Genome-scale screen for DNA methylation-based detection markers for ovarian cancer
Mihaela Campan, Melissa Moffitt, Sahar Houshdaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2004
Detection of residual subclinical ovarian carcinoma after completion of adjuvant chemotherapy
Mory Nouriani, Afshin Bahador, Jonathan S Berek, et al.
Oncotarget
|
December 22, 2016
Aberrant regulation of RANKL/OPG in women at high risk of developing breast cancer
Stefan Kiechl, Daniel Schramek, Martin Widschwendter, et al.
Genome Medicine
|
July 19, 2022
Correction: Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women
Thomas E Bartlett, Iona Evans, Allison Jones, et al.
Genome Medicine
|
June 14, 2022
Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women
Thomas E Bartlett, Iona Evans, Allison Jones, et al.
Cell Metabolism
|
June 23, 2015
A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan
Sebastian Brandhorst, In Young Choi, Min Wei, et al.
Genome Medicine
|
October 27, 2015
HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer
Andrew E Teschendorff, Shih-Han Lee, Allison Jones, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 68) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 68 results.
Cancers
|
March 28, 2024
Natural Killer Cell Dysfunction in Premenopausal <i>BRCA1</i> Mutation Carriers: A Potential Mechanism for Ovarian Carcinogenesis
Shaun Haran, Kantaraja Chindera, May Sabry, et al.
Plos One
|
December 14, 2011
Genome-scale screen for DNA methylation-based detection markers for ovarian cancer
Mihaela Campan, Melissa Moffitt, Sahar Houshdaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2004
Detection of residual subclinical ovarian carcinoma after completion of adjuvant chemotherapy
Mory Nouriani, Afshin Bahador, Jonathan S Berek, et al.
Oncotarget
|
December 22, 2016
Aberrant regulation of RANKL/OPG in women at high risk of developing breast cancer
Stefan Kiechl, Daniel Schramek, Martin Widschwendter, et al.
Genome Medicine
|
July 19, 2022
Correction: Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women
Thomas E Bartlett, Iona Evans, Allison Jones, et al.
Genome Medicine
|
June 14, 2022
Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women
Thomas E Bartlett, Iona Evans, Allison Jones, et al.
Cell Metabolism
|
June 23, 2015
A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan
Sebastian Brandhorst, In Young Choi, Min Wei, et al.
Genome Medicine
|
October 27, 2015
HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer
Andrew E Teschendorff, Shih-Han Lee, Allison Jones, et al.
Page
of 7